Assess arm endurance measurement reliability
- Trial ID
- NCT06482502
- Official Title
- Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
- Goal
- Assess arm endurance measurement reliability
- Status
- RECRUITING
- Sponsor
- Emre Şenocak
- Study Type
- OBSERVATIONAL
- Enrollment
- 34 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to see whether a simple six minute pegboard and ring test gives valid, repeatable measures of arm endurance in people with Parkinson's. Participants move rings between pegs for six minutes while researchers check how consistent and accurate the results are, this is an observational assessment rather than a treatment so it does not change or interact with medications like levodopa. They are enrolling people aged 45 to 75 with mild to moderate Parkinson's (Hoehn and Yahr stage 3 or lower), who have full shoulder motion, no recent intensive rehab, and no severe heart disease, upper limb orthopedic problems, other neurological diagnoses, uncorrected vision or significant cognitive impairment, and no recent medication changes.
Locations
- İstanbul Medilife Beylikdüzü Hospital, Istanbul, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see whether a simple six minute pegboard and ring test gives valid, repeatable measures of arm endurance in people with Parkinson's. Participants move rings between pegs for six minutes while researchers check how consistent and accurate the results are, this is an observational assessment rather than a treatment so it does not change or interact with medications like levodopa. They are enrolling people aged 45 to 75 with mild to moderate Parkinson's (Hoehn and Yahr stage 3 or lower), who have full shoulder motion, no recent intensive rehab, and no severe heart disease, upper limb orthopedic problems, other neurological diagnoses, uncorrected vision or significant cognitive impairment, and no recent medication changes.
- Who can participate?
- Participants must be between 45 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.